CNIPA.AI
返回搜索
档案

INFLUENZA VACCINES WITH REDUCED AMOUNTS OF SQUALENE

发明专利审中
21权利要求 · 2 独立
§ Ⅰ

卷宗概要

发明人

Mario CONTORNI; Derek O'HAGAN; Nicola GROTH

IPC 分类

A61K 39/145A61K 39/A61K 39/12C12N 7/

CPC 分类

A61K39/145A61K39/12C12N7/A61K2039/545A61K2039/55566A61K2039/70C12N2760/16134C12N2760/16234

Influenza vaccines include hemagglutinin from at least one influenza A virus strain and at least one influenza B virus strain. They also include an oil-in-water emulsion adjuvant with submicron oil droplets, comprising squalene. In some embodiments the hemagglutinin concentration is >12 μg/ml per strain. In some embodiments the squalene concentration is <19 mg/ml. In some embodiments the vaccine is mercury-free. In some embodiments the vaccine has a unit dose volume between 0.2-0.3 mL. In some embodiments the squalene concentration is 9.75 mg/mL or 4.88 mg/mL. In some embodiments the vaccine includes antigens from two influenza A virus strains and two influenza B virus strains.

原文(中文)

Influenza vaccines include hemagglutinin from at least one influenza A virus strain and at least one influenza B virus strain. They also include an oil-in-water emulsion adjuvant with submicron oil droplets, comprising squalene. In some embodiments the hemagglutinin concentration is >12 μg/ml per strain. In some embodiments the squalene concentration is <19 mg/ml. In some embodiments the vaccine is mercury-free. In some embodiments the vaccine has a unit dose volume between 0.2-0.3 mL. In some embodiments the squalene concentration is 9.75 mg/mL or 4.88 mg/mL. In some embodiments the vaccine includes antigens from two influenza A virus strains and two influenza B virus strains.